Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma
Novel agents such as lenalidomide have demonstrated responses similar to high-dose melphalan and autologous stem cell transplant in multiple myeloma. For patients who are started on lenalidomide, it is advisable to collect stem cells early if future transplant is contemplated. We are reporting a pat...
Main Authors: | Rishi Agarwal, Muneer H. Abidi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2012-12-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hr/article/view/4509 |
Similar Items
-
Chemomobilization with cyclophosphamide and filgrastim in multiple myeloma patients following lenalidomide treatment
by: Gerfen, Ashlee
Published: (2012) -
Chemomobilization with Cyclophosphamide and Filgrastim in Multiple Myeloma Patients Following Lenalidomide Treatment
by: Gerfen, Ashlee, et al.
Published: (2012) -
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
by: Rocío Parody, et al.
Published: (2020-05-01) -
Advances in multiple myeloma therapy during two past decades
by: Ivan Spicka
Published: (2014-06-01) -
Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells
by: MA Kucher, et al.
Published: (2016-04-01)